Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Fred Hutchinson Cancer Center
City of Hope Medical Center
New York Medical College
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
Children's Cancer Group, China
BeiGene
European Organisation for Research and Treatment of Cancer - EORTC
City of Hope Medical Center
Seagen Inc.
University of Nebraska
University of Milano Bicocca
Eastern Cooperative Oncology Group
University of Milano Bicocca
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Children's Cancer Group, China
Mayo Clinic
Universität des Saarlandes
Takeda
Fox Chase Cancer Center
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Canadian Cancer Trials Group
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Fred Hutchinson Cancer Center
Novartis
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
University of Chicago
Barbara Ann Karmanos Cancer Institute
Case Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Wake Forest University Health Sciences
University of Arizona
Royal Marsden NHS Foundation Trust
Beth Israel Deaconess Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Washington
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
Seagen Inc.